Angiopoietin-1 and endostatin levels in cord plasma predict the development of bronchopulmonary dysplasia in preterm infants

Journal of Tropical Pediatrics

Volumn 57, Issue 5, 2011, Pages 385-388

  Mohamed, Walid Abdel Wahab ^a,b   Niyazy, Walid H ^a,c   Mahfouz, Ahmed A ^a  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b MINIA UNIVERSITY   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Angiopoietin 1; Bronchopulmonary dysplasia; Endostatin; Preterm infants

Indexed keywords

ANGIOPOIETIN 1; ENDOSTATIN;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; PREMATURITY; UMBILICAL CORD BLOOD;

ANGIOPOIETIN-1; BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84855211604     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq112     Document Type: Article

References (19)

1. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9.
2. Bhandari A, Bhandari V. Bronchopulmonary dysplasia: an update. Indian J Pediatr 2007;74:73-7.
3. Zoban P, Cerny M. Immature lung and acute lung injury. Physiol Res 2003;52:507-16.
4. Jakkula M, Le Cras TD, Gebb S, et al. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000;279:L600-7.
5. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-17.
6. Thebaud B. Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity. Neonatology 2007;91:291-7.
7. Makinde T, Agrawal DK. Intra and extra-vascular trans-membrane signaling of angiopoietin-1-Tie2 receptor in health and disease. J Cell Mol Med 2008; 12:810-28.
8. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
9. Yamaguchi N, Anand-Apte B, Lee M, et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 1999;18:4414-23.
10. Dixelius J, Larsson H, Sasaki T, et al. Endostatininduced tyrosine kinase signaling through the shb adaptor protein regulates endothelial cell apoptosis. Blood 2000;95:3403-3411.
11. Levy M, Maurey C, Chailley-Heu B, et al. Developmental changes in endothelial vasoactive and angiogenic growth factors in the human perinatal lung. Pediatr Res 2005;57:248-53.
12. Cullen A, Van Marter LJ, Allred EN, et al. Urine bombesin like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2002;165:1093-7.
13. Danan C, Franco ML, Jarreau PH, et al. High concentrations of keratinocyte growth factor in airways of premature infants predicted absence ofbronchopulmonary dysplasia. Am J Respir Crit Care Med 2002;165:1384-7.
14. Thomas W, Seidensoinner S, Boris W, et al. Airway concentrations of angiopoietin-1 and endostatin in ventilated extremely premature infants are decreased after funisitis and unbalanced with bronchopulmonary dysplasia/ death. Pediatric Res 2009;65:468-73.
15. Janer J, Andersson S, Haglund C, et al. Pulmonary endostatin perinatally and in lung injury of the newborn infant. Pediatrics 2007;119:241-6.
16. Lassus P, Ristimaki A, Ylikorkala O, et al. Vascular endothelial growth factor in the human preterm lung. Am J Respir Crit Care Med 1999;159:1429-33.
17. Thebaud B, Ladha F, Michelakis ED, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005;112:2477-86.
18. Abdollahi A, Hahnfeldt P, Maercker C, et al. Endostatin's antiangiogenic signaling network. Mol Cell 2004;13:649-63.
19. Dziankowska-Bartkowiak B, Waszczykowska E, Dziankowska-Zaboroszczyk E, et al. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis- association with pulmonary involvement. Clin Exp Rheumatol 2006;24:508-13.